陶醉 发表于 2025-3-23 10:49:53

http://reply.papertrans.cn/23/2284/228314/228314_11.png

Ibd810 发表于 2025-3-23 16:47:43

http://reply.papertrans.cn/23/2284/228314/228314_12.png

的是兄弟 发表于 2025-3-23 19:57:32

Biochemical and Molecular Mechanisms of Cisplatin Resistance,ro-platinum(II); Figure 1) and its analogs fall into at least 13 clustered regions, each reflecting a distinct mechanism of action.. Many of these analogs have not been investigated in depth to unravel their fundamental mechanism of action. Indeed, almost 30 years after its clinical acceptance as a

极大痛苦 发表于 2025-3-24 00:27:39

http://reply.papertrans.cn/23/2284/228314/228314_14.png

ellagic-acid 发表于 2025-3-24 05:13:03

Clinical Pharmacology of Melphalan and Its Implications for Clinical Resistance to Anticancer Agentwas reported by Bergel and Stock.. Its design was an outgrowth of studies performed during and following World War II on the mechanisms of mustard gas effects on biological systems. A summary of these early studies by Philips Philips. is of historical interest; it also serves as a model description

SNEER 发表于 2025-3-24 10:09:01

http://reply.papertrans.cn/23/2284/228314/228314_16.png

悬崖 发表于 2025-3-24 11:01:31

Genomic Approaches to Clinical Drug Resistance,vances in methodologies, such as microarray analysis for gene expression profiling, and the even larger choice ofmethods now developed for scoring genetic variations among populations, will have a profound impact on the way we understand health and disease. The drug resistance phenotype in human tum

青少年 发表于 2025-3-24 18:06:40

Christopher Doherty,Ruby Grewal(P-gp) that are encoded by the MDR gene family. The second mechanism is exemplified by the multidrug resistance protein (MRP). Both P-gp and MRP contain ATP-binding cassettes and therefore belong to the ABC superfamily of membrane transporters

亲属 发表于 2025-3-24 19:06:02

http://reply.papertrans.cn/23/2284/228314/228314_19.png

Femish 发表于 2025-3-24 23:20:45

http://reply.papertrans.cn/23/2284/228314/228314_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Clinically Relevant Resistance in Cancer Chemotherapy; Borje Andersson,David Murray Book 2002 Springer Science+Business Media New York 200